Salona Global Medical Device Corporation (TSE:EVMT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Evome Medical Technologies Inc. has announced a positive turnaround with their fiscal year 2023 results, achieving a strong fourth quarter that led to a positive annual Adjusted EBITDA. The company generated annual revenues of $62.6 million and a gross margin of $22.5 million, marking a significant recovery from a challenging first half of the year. The turnaround strategy included restructuring debt, divesting non-core units, and launching new products, with plans for continued growth and debt reduction.
For further insights into TSE:EVMT stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money